Axsome Therapeutics Inc — Balance Sheet (NASDAQ:AXSM) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 186.13 M87.79 M331.48 M588.24 M568.5 M689.8 M Total liabilities 72.34 M72.15 M221.92 M397.26 M511.48 M601.51 M Total equity 113.79 M15.63 M109.56 M190.98 M57.02 M88.3 M Total liabilities & shareholders' equities 186.13 M87.79 M331.48 M588.24 M568.5 M689.8 M Total debt —————— Net debt ——————

新闻

Stock Market Can't Hold Key Levels Amid AI Concerns; Nvidia Tumbles Despite Strong Earnings: Weekly Review

Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales

UBS上调Axsome Therapeutics目标价,因销售团队扩张

UBS raises Axsome Therapeutics stock price target on sales force expansion

Wolfe Research首次覆盖Axsome股票,给予跑赢大盘评级

Wolfe Research initiates Axsome stock with outperform rating

RBC Capital上调Axsome Therapeutics目标价

RBC Capital raises Axsome Therapeutics price target on earnings

Axsome在抑郁症试验中为首位患者给予solriamfetol药物

Axsome doses first patient in depression trial with solriamfetol

古根海姆因强劲销售将Axsome目标价上调至220美元